N/A
N=27
Effectiveness of Telemedicine Home Assessments for Identification and Reduction of Asthma Triggers
Asthma in Children
Bottom Line
View on ClinicalTrials.gov: NCT04896502 ↗Enrolled (actual)
27
Serious AEs
0.0%
Results posted
Sep 2024
Primary outcome: Primary: Number of Subjects With a Significant Change in D. Pteronyssinus Levels at End of Study Evaluation — 0; 0 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Standard of Care Education (Behavioral); Interactive Video (IAV) Telemedicine (Other)
- Age
- Pediatric, Adult · 5+ yrs
- Sex
- All
- Sponsor
- University of Arkansas
- Primary completion
- Aug 2022
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Number of Subjects With a Significant Change in D. Pteronyssinus Levels at End of Study Evaluation |
0; 0 | — |
| SECONDARY Differences in ACT Score Between Telemedicine and Standard of Care Groups |
23.3; 21.25; 23.3; 22 | — |
| SECONDARY Patient Satisfaction |
4; 4; 2; 1; 0; 0 | — |
Summary
The study is about comparing asthma home assessments/interventions by telemedicine compared to providing education alone. Interactive Video (IAV) defines telemedicine. It allows two-way communication in real-time with both audio and visual communication between the subject and someone from the study team. It is similar to using Face Time on a mobile device. Asthma home assessments/interventions are used to identify things in a home that can make asthma symptoms worse, called triggers. Reducing these triggers in the home can improve asthma.
Eligibility Criteria
Inclusion Criteria
- Age ≥ 5 years and ≤ 18 years
- Have a diagnosis of persistent asthma as defined by national guidelines criteria1
- Patient receives care in Arkansas Children's Hospital (ACH) primary care, in patient and/or specialty clinics
- Patient has had at least one or more acute exacerbations of asthma within the 12 months prior to enrollment that led to an emergency department visit, hospital admission, or prescription for systemic steroids
- English speaking participants/parents
- Access to WIFI, smartphone or mobile device (tablet)
Exclusion Criteria
- Age 18 years
- Non-English speaking participants/parents
- Patients not receiving primary and/or asthma specialty care or inpatient services at ACH
- Inability of patient or family to participate in TM evaluation due to lack of access to WIFI or smartphone or mobile device
Data sourced from ClinicalTrials.gov (NCT04896502). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.